ArticleScientific reports2026
Development and characterization of rat hindlimb ischemia models mimicking peripheral arterial disease severity.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Peripheral arterial disease (PAD) is a progressive atherosclerotic disorder that reduces blood flow to the lower extremities, leading to skeletal muscle degeneration, functional decline, and limb loss in advanced stages. To enable rigorous preclinical evaluation of regenerative therapies across disease stages, we developed and quantitatively characterized three rat hindlimb ischemia models representing graded arterial insufficiency: iliac artery ligation (Iliac), femoral artery ligation and excision (Femoral), and combined femoral plus popliteal artery ligation and excision (Fem/Pop). Laser Doppler perfusion imaging demonstrated an immediate reduction to approximately 60–65% of baseline in Iliac, 40–50% in Femoral, and less than 30% in Fem/Pop limbs. Perfusion recovery occurred earliest in the Iliac model, with delayed recovery in the Femoral and Fem/Pop models, while overall temporal recovery trends were comparable by mixed-effects analysis. Histological and quantitative morphometric analyses at the chronic endpoint revealed progressively severe muscle remodeling with increasing ischemic burden, including increased centrally nucleated fibers and fibrosis, most pronounced in the Fem/Pop model. Oxidative stress markers trended higher with increasing ischemia severity but did not differ significantly among models. Among the three models, Fem/Pop produced the most sustained clinical ischemia and structural remodeling, while regenerative, inflammatory, and biochemical endpoints exhibit heterogeneity at chronic stages, enabling stage-appropriate evaluation of vascular and regenerative therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.